Cancer research (IMAGE)
Caption
For many patients with a deadly type of brain cancer called glioblastoma, chemotherapy resistance is a big problem. But now, Virginia Tech researchers led by Zhi Sheng (center) of the Fralin Biomedical Research Institute at VTC may have moved a step closer to a solution.
Credit
Clayton Metz/Virginia Tech
Usage Restrictions
None
License
Original content